Skip to main content
Livermore
Livermore
ZHEN

Pinnacle Associates Ltd

SEC CIK
0000743127
Latest filing
Aug 3, 2026

RARE holding history

Ultragenyx Pharmaceutical Inc. in every 13F filed by Pinnacle Associates Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RARE overviewAll 13F holders of RAREFull Q2 2026 holdings

Shares (Q2 2026)
131,104
Value
$4.38M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of RARE by Pinnacle Associates Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026131,104$4.38M<0.1%+28,394+27.6%AddedHolders
Q1 2026102,710$2.15M<0.1%−8,850−7.9%ReducedHolders
Q4 2025111,560$2.57M<0.1%−3,285−2.9%ReducedHolders
Q3 2025114,845$3.45M<0.1%+577+0.5%AddedHolders
Q2 2025114,268$4.15M0.1%−29,107−20.3%ReducedHolders
Q1 2025143,375$5.19M0.1%−5,118−3.4%ReducedHolders
Q4 2024148,493$6.25M0.1%+29,133+24.4%AddedHolders
Q3 2024119,360$5.71M0.1%−41,660−25.9%ReducedHolders
Q2 2024161,020$6.62M0.1%+41,633+34.9%AddedHolders
Q1 2024119,387$5.57M0.1%+270.0%AddedHolders
Q4 2023119,360$5.71M0.1%+50.0%AddedHolders
Q3 2023119,355$4.26M0.1%−3,841−3.1%ReducedHolders
Q2 2023123,196$5.68M0.1%−3,201−2.5%ReducedHolders
Q1 2023126,397$5.07M0.1%−2,039−1.6%ReducedHolders
Q4 2022128,436$5.95M0.1%−1,982−1.5%ReducedHolders
Q3 2022130,418$5.40M0.1%−3,640−2.7%ReducedHolders
Q2 2022134,058$8.00M0.2%−2,221−1.6%ReducedHolders
Q1 2022136,279$9.90M0.2%−5,295−3.7%ReducedHolders
Q4 2021141,574$11.9M0.2%−782−0.5%ReducedHolders
Q3 2021142,356$12.8M0.2%−4,159−2.8%ReducedHolders
Q2 2021146,515$14.0M0.3%+1,225+0.8%AddedHolders
Q1 2021145,290$16.5M0.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.